Cargando…
Emerging Diseases: Overview
Emerging infectious diseases are diseases that are either new, are newly recognized, or are increasing in prevalence in new areas. Resurgent diseases are also usually grouped in this category, as is antimicrobial resistance. These diseases have been given formal recognition in the past two decades,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150206/ http://dx.doi.org/10.1016/B978-012373960-5.00453-6 |
_version_ | 1783520978877284352 |
---|---|
author | Mayer, J.D. |
author_facet | Mayer, J.D. |
author_sort | Mayer, J.D. |
collection | PubMed |
description | Emerging infectious diseases are diseases that are either new, are newly recognized, or are increasing in prevalence in new areas. Resurgent diseases are also usually grouped in this category, as is antimicrobial resistance. These diseases have been given formal recognition in the past two decades, although a historical outlook demonstrates that the phenomenon has probably been persistent, although largely undetected, through recorded history. Emergence has accelerated recently, driven by factors such as demographic change, land use change, increased rapidity and frequency of intercontinental transportation, and other mostly social trends. Continued infectious disease emergence poses, and will continue to pose, significant challenges for public health and for basic science. |
format | Online Article Text |
id | pubmed-7150206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71502062020-04-13 Emerging Diseases: Overview Mayer, J.D. International Encyclopedia of Public Health Article Emerging infectious diseases are diseases that are either new, are newly recognized, or are increasing in prevalence in new areas. Resurgent diseases are also usually grouped in this category, as is antimicrobial resistance. These diseases have been given formal recognition in the past two decades, although a historical outlook demonstrates that the phenomenon has probably been persistent, although largely undetected, through recorded history. Emergence has accelerated recently, driven by factors such as demographic change, land use change, increased rapidity and frequency of intercontinental transportation, and other mostly social trends. Continued infectious disease emergence poses, and will continue to pose, significant challenges for public health and for basic science. 2008 2008-08-26 /pmc/articles/PMC7150206/ http://dx.doi.org/10.1016/B978-012373960-5.00453-6 Text en Copyright © 2008 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mayer, J.D. Emerging Diseases: Overview |
title | Emerging Diseases: Overview |
title_full | Emerging Diseases: Overview |
title_fullStr | Emerging Diseases: Overview |
title_full_unstemmed | Emerging Diseases: Overview |
title_short | Emerging Diseases: Overview |
title_sort | emerging diseases: overview |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150206/ http://dx.doi.org/10.1016/B978-012373960-5.00453-6 |
work_keys_str_mv | AT mayerjd emergingdiseasesoverview |